Literature DB >> 21954942

Structure and properties of the Ca(2+)-binding CUB domain, a widespread ligand-recognition unit involved in major biological functions.

Christine Gaboriaud1, Lynn Gregory-Pauron, Florence Teillet, Nicole M Thielens, Isabelle Bally, Gérard J Arlaud.   

Abstract

CUB domains are 110-residue protein motifs exhibiting a β-sandwich fold and mediating protein-protein interactions in various extracellular proteins. Recent X-ray structural and mutagenesis studies have led to the identification of a particular CUB domain subset, cbCUB (Ca(2+)-binding CUB domain). Unlike other CUB domains, these harbour a homologous Ca(2+)-binding site that underlies a conserved binding site mediating ionic interaction between two of the three conserved acidic Ca(2+) ligands and a basic (lysine or arginine) residue of a protein ligand, similar to the interactions mediated by the low-density lipoprotein receptor family. cbCUB-mediated protein-ligand interactions usually involve multipoint attachment through several cbCUBs, resulting in high-affinity binding through avidity, despite the low affinity of individual interactions. The aim of the present review is to summarize our current knowledge about the structure and functions of cbCUBs, which represent the majority of the known CUB repertoire and are involved in a variety of major biological functions, including immunity and development, as well as in various cancer types. Examples discussed in the present review include a wide range of soluble and membrane-associated human proteins, as well as some archaeal and invertebrate proteins. The fact that these otherwise unrelated proteins share a common Ca(2+)-dependent ligand-binding ability suggests a mechanism inherited from very primitive ancestors. The information provided in the present review should stimulate further investigations on the crucial interactions mediated by cbCUB-containing proteins. © The Authors Journal compilation
© 2011 Biochemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21954942     DOI: 10.1042/BJ20111027

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites.

Authors:  Isabelle Bally; Sarah Ancelet; Christine Moriscot; Florence Gonnet; Alberto Mantovani; Régis Daniel; Guy Schoehn; Gérard J Arlaud; Nicole M Thielens
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

2.  The auxiliary glutamate receptor subunit dSol-1 promotes presynaptic neurotransmitter release and homeostatic potentiation.

Authors:  Beril Kiragasi; Pragya Goel; Sarah Perry; Yifu Han; Xiling Li; Dion Dickman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-24       Impact factor: 11.205

Review 3.  Neuropilins and liver.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

4.  Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake.

Authors:  Ricquita D Pollard; Christopher N Blesso; Manal Zabalawi; Brian Fulp; Mark Gerelus; Xuewei Zhu; Erica W Lyons; Nebil Nuradin; Omar L Francone; Xiang-An Li; Daisy Sahoo; Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

5.  Variants in the pancreatic CUB and zona pellucida-like domains 1 (CUZD1) gene in early-onset chronic pancreatitis - A possible new susceptibility gene.

Authors:  Agnieszka Magdalena Rygiel; Lara Sophie Unger; Franziska Lena Sörgel; Emmanuelle Masson; Ryotaro Matsumoto; Maren Ewers; Jian-Min Chen; Peter Bugert; Louis Buscail; Tomasz Gambin; Grzegorz Oracz; Maria Winiewska-Szajewska; Agnieszka Mianowska; Jarosław Poznanski; Joanna Kosińska; Piotr Stawinski; Rafał Płoski; Dorota Koziel; Stanisław Gluszek; Helmut Laumen; Fredrik Lindgren; J Matthias Löhr; Anna Orekhova; Vinciane Rebours; Jonas Rosendahl; Andrea Párniczky; Péter Hegyi; Akira Sasaki; Fumiya Kataoka; Yu Tanaka; Shin Hamada; Miklós Sahin-Tóth; Eszter Hegyi; Claude Férec; Atsushi Masamune; Heiko Witt
Journal:  Pancreatology       Date:  2022-05-01       Impact factor: 3.977

6.  Procollagen C-proteinase enhancer grasps the stalk of the C-propeptide trimer to boost collagen precursor maturation.

Authors:  Jean-Marie Bourhis; Sandrine Vadon-Le Goff; Hassnae Afrache; Natacha Mariano; Daniel Kronenberg; Nicole Thielens; Catherine Moali; David J S Hulmes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-02       Impact factor: 11.205

Review 7.  Function of members of the neuropilin family as essential pleiotropic cell surface receptors.

Authors:  Matthew W Parker; Hou-Fu Guo; Xiaobo Li; Andrew D Linkugel; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2012-11-14       Impact factor: 3.162

8.  Architecture of the Sema3A/PlexinA4/Neuropilin tripartite complex.

Authors:  Defen Lu; Guijun Shang; Xiaojing He; Xiao-Chen Bai; Xuewu Zhang
Journal:  Nat Commun       Date:  2021-05-26       Impact factor: 17.694

Review 9.  Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target.

Authors:  Endeshaw Chekol Abebe; Teklie Mengie Ayele; Zelalem Tilahun Muche; Tadesse Asmamaw Dejenie
Journal:  Biologics       Date:  2021-05-06

10.  Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.

Authors:  Na Zhu; Emilia M Swietlik; Carrie L Welch; Michael W Pauciulo; Nicholas W Morrell; Yufeng Shen; Stefan Gräf; William C Nichols; Wendy K Chung; Jacob J Hagen; Xueya Zhou; Yicheng Guo; Johannes Karten; Divya Pandya; Tobias Tilly; Katie A Lutz; Jennifer M Martin; Carmen M Treacy; Erika B Rosenzweig; Usha Krishnan; Anna W Coleman; Claudia Gonzaga-Jauregui; Allan Lawrie; Richard C Trembath; Martin R Wilkins
Journal:  Genome Med       Date:  2021-05-10       Impact factor: 15.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.